All the news Showing 5 of 15 articles from: Life after the cureGet an RSS feed of these articles Show All news infohep newsEditors' picks from other sources Hepatitis C virus reinfection is uncommon after being cured with DAAs Liz Highleyman / 22 May 2017 Most people on opiate substitution therapy were successfully treated for hepatitis C with an interferon-free regimen of grazoprevir/elbasvir (Zepatier), and only a small number became reinfected during three years of follow-up, researchers reported ... HCV treatment allows one in four people to come off the transplant waiting list Keith Alcorn / 24 April 2017 Around one in four people with hepatitis C and decompensated cirrhosis came off the transplant waiting list in Europe after direct-acting antiviral treatment, and very few had any subsequent liver-related ... Are people with HIV and HCV co-infection who are cured of hepatitis C with DAAs at increased risk for liver cancer? Liz Highleyman / 27 February 2017 People with HIV and hepatitis C virus (HCV) co-infection who are successfully treated for hepatitis C using interferon-free direct-acting antiviral (DAA) therapy do not appear to have an increased likelihood of developing hepatocellular ... People with HCV attaining SVR continue to have increased mortality risk but this is due to alcohol and drug use Michael Carter / 03 October 2016 Mortality rates among people with hepatitis C virus (HCV) who attain a sustained virological response after HCV treatment are approximately twice as high as those expected in the general population, Scottish investigators report ... Risk of reinfection is a concern after successful hepatitis C treatment Liz Highleyman / 28 September 2016 People on opiate agonist substitution therapy can be successfully treated with grazoprevir/elbasvir (Zepatier) – achieving cure rates similar to those of the population as a whole – but some people are reinfected ... ← Prev12Next → Other pages in this section Latest news All the news Hepatitis A Hepatitis B Hepatitis C Hepatitis D Hepatitis E Coronavirus NAFLD Treatment for hepatocellular carcinoma Transmission, epidemiology and prevention Health services, policy and advocacy Social issues Conference news Email bulletin archive